Total Lymphocyte Count (TLC) Is a Useful Tool for the Timing of Opportunistic Infection Prophylaxis in India and Other Resource-Constrained Countries
- 1 December 2002
- journal article
- research article
- Published by Wolters Kluwer Health in JAIDS Journal of Acquired Immune Deficiency Syndromes
- Vol. 31 (4), 378-383
- https://doi.org/10.1097/00126334-200212010-00002
Abstract
In most resource-constrained countries, CD4 cell count testing is prohibitively expensive for routine clinical use and is not widely available. As a result, physicians are often required to make decisions about opportunistic infection (OI) chemoprophylaxis without a laboratory evaluation of HIV stage and level of immunosuppression. To evaluate the correlation of total lymphocyte count (TLC), an inexpensive and widely available parameter, to CD4 count. To determine a range of TLC cutoffs for the initiation of OI prophylaxis that is appropriate for resource-constrained settings. Spearman correlation between CD4 count and TLC was assessed in patients attending an HIV/AIDS clinic in South India. Positive predictive value (PPV), negative predictive value (NPV), and sensitivity and specificity of various TLC cutoffs were computed for CD4 count 3 High degree of correlation was noted between 650 paired CD4 and TLC counts (r = 0.744). TLC 3 TLC could serve as a low-cost tool for determining both a patient’s risk of OI and when to initiate prophylaxis in resource-constrained settings. PPV, NPV, sensitivity, and specificity maximally aggregated at TLC 3Keywords
This publication has 15 references indexed in Scilit:
- Initiating co-trimoxazole prophylaxis in HIV-infected patients in Africa: an evaluation of the provisional WHO/UNAIDS recommendationsAIDS, 2001
- GLOBAL DIMENSIONS OF THE AIDS EPIDEMIC:: Implications for Prevention and CareInfectious Disease Clinics of North America, 2000
- Efficacy of trimethoprim-sulphamethoxazole prophylaxis to decrease morbidity and mortality in HIV-1-infected patients with tuberculosis in Abidjan, Côte d'Ivoire: a randomised controlled trialThe Lancet, 1999
- Early chemoprophylaxis with trimethoprim-sulphamethoxazole for HIV-1-infected adults in Abidjan, Côte d'Ivoire: a randomised trialThe Lancet, 1999
- Plasma Viral Load and CD4+ Lymphocytes as Prognostic Markers of HIV-1 InfectionAnnals of Internal Medicine, 1997
- Correlation between total and CD4 lymphocyte counts in HIV infection: not making the good an enemy of the not so perfectInternational Journal of STD & AIDS, 1996
- Delayed-Type Hypersensitivity Testing in Tanzanian Adults with HIV InfectionJAIDS Journal of Acquired Immune Deficiency Syndromes, 1996
- Total lymphocyte count as a predictor of absolute CD4+ count and CD4+ percentage in HIV-infected personsPublished by American Medical Association (AMA) ,1993
- The Relationship of Total Lymphocyte Count to CD4 Lymphocyte Counts in Patients Infected with Human Immunodeficiency VirusThe American Journal of the Medical Sciences, 1992
- The Risk ofPneumocystis cariniiPneumonia among Men Infected with Human Immunodeficiency Virus Type 1New England Journal of Medicine, 1990